vs
CHINA PHARMA HOLDINGS, INC.（CPHI）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
Rigetti Computing, Inc.的季度营收约是CHINA PHARMA HOLDINGS, INC.的1.5倍（$1.9M vs $1.2M），CHINA PHARMA HOLDINGS, INC.净利率更高（-99.7% vs -974.7%，领先875.0%），CHINA PHARMA HOLDINGS, INC.同比增速更快（8.1% vs -17.9%），CHINA PHARMA HOLDINGS, INC.自由现金流更多（$151.5K vs $-19.5M），过去两年CHINA PHARMA HOLDINGS, INC.的营收复合增速更高（-5.4% vs -21.8%）
太阳药业是总部位于印度孟买的跨国制药企业，在全球逾100个国家生产销售药品制剂与原料药，是印度规模最大的制药企业，同时也是全球第四大特色仿制药企业。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
CPHI vs RGTI — 直观对比
营收规模更大
RGTI
是对方的1.5倍
$1.2M
营收增速更快
CPHI
高出26.0%
-17.9%
净利率更高
CPHI
高出875.0%
-974.7%
自由现金流更多
CPHI
多$19.6M
$-19.5M
两年增速更快
CPHI
近两年复合增速
-21.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2M | $1.9M |
| 净利润 | $-1.2M | $-18.2M |
| 毛利率 | 12.3% | 34.9% |
| 营业利润率 | -97.9% | -1209.7% |
| 净利率 | -99.7% | -974.7% |
| 营收同比 | 8.1% | -17.9% |
| 净利润同比 | 0.2% | 88.1% |
| 每股收益（稀释后） | $-0.17 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CPHIRGTI
| Q4 25 | $1.2M | $1.9M | ||
| Q3 25 | $756.2K | $1.9M | ||
| Q2 25 | $1.0M | $1.8M | ||
| Q1 25 | $1.1M | $1.5M | ||
| Q4 24 | $1.1M | $2.3M | ||
| Q3 24 | $1.1M | $2.4M | ||
| Q2 24 | $924.9K | $3.1M | ||
| Q1 24 | $1.4M | $3.1M |
净利润CPHIRGTI
| Q4 25 | $-1.2M | $-18.2M | ||
| Q3 25 | $-651.5K | $-201.0M | ||
| Q2 25 | $-528.4K | $-39.7M | ||
| Q1 25 | $-785.6K | $42.6M | ||
| Q4 24 | $-1.2M | $-153.0M | ||
| Q3 24 | $-1.1M | $-14.8M | ||
| Q2 24 | $-1.4M | $-12.4M | ||
| Q1 24 | $-955.9K | $-20.8M |
毛利率CPHIRGTI
| Q4 25 | 12.3% | 34.9% | ||
| Q3 25 | -7.9% | 20.7% | ||
| Q2 25 | -8.5% | 31.4% | ||
| Q1 25 | -12.0% | 30.0% | ||
| Q4 24 | -14.2% | 44.1% | ||
| Q3 24 | -47.2% | 50.6% | ||
| Q2 24 | -109.8% | 64.5% | ||
| Q1 24 | -21.2% | 49.1% |
营业利润率CPHIRGTI
| Q4 25 | -97.9% | -1209.7% | ||
| Q3 25 | -83.1% | -1055.4% | ||
| Q2 25 | -63.6% | -1103.9% | ||
| Q1 25 | -66.8% | -1469.6% | ||
| Q4 24 | -105.5% | -813.3% | ||
| Q3 24 | -98.6% | -729.4% | ||
| Q2 24 | -150.4% | -521.2% | ||
| Q1 24 | -66.9% | -543.4% |
净利率CPHIRGTI
| Q4 25 | -99.7% | -974.7% | ||
| Q3 25 | -86.2% | -10321.9% | ||
| Q2 25 | -51.5% | -2201.8% | ||
| Q1 25 | -69.1% | 2895.3% | ||
| Q4 24 | -108.0% | -6726.5% | ||
| Q3 24 | -101.6% | -623.8% | ||
| Q2 24 | -155.5% | -402.5% | ||
| Q1 24 | -69.8% | -680.6% |
每股收益（稀释后）CPHIRGTI
| Q4 25 | $-0.17 | $-0.08 | ||
| Q3 25 | $-0.17 | $-0.62 | ||
| Q2 25 | $-0.16 | $-0.13 | ||
| Q1 25 | $-0.24 | $0.13 | ||
| Q4 24 | $-0.45 | $-0.80 | ||
| Q3 24 | $-0.65 | $-0.08 | ||
| Q2 24 | $-0.89 | $-0.07 | ||
| Q1 24 | $-0.72 | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $345.1K | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $22.7M | $546.2M |
| 总资产 | $31.0M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CPHIRGTI
| Q4 25 | $345.1K | $44.9M | ||
| Q3 25 | $267.6K | $26.1M | ||
| Q2 25 | $600.0K | $57.2M | ||
| Q1 25 | $400.0K | $37.2M | ||
| Q4 24 | $626.9K | $67.7M | ||
| Q3 24 | $700.0K | $20.3M | ||
| Q2 24 | — | $20.7M | ||
| Q1 24 | — | $35.1M |
股东权益CPHIRGTI
| Q4 25 | $22.7M | $546.2M | ||
| Q3 25 | $8.3M | $371.8M | ||
| Q2 25 | $6.5M | $553.3M | ||
| Q1 25 | $7.0M | $207.1M | ||
| Q4 24 | $7.7M | $126.6M | ||
| Q3 24 | $6.5M | $122.8M | ||
| Q2 24 | $7.4M | $122.2M | ||
| Q1 24 | $8.3M | $115.6M |
总资产CPHIRGTI
| Q4 25 | $31.0M | $666.6M | ||
| Q3 25 | $15.8M | $630.3M | ||
| Q2 25 | $13.8M | $636.7M | ||
| Q1 25 | $14.2M | $269.1M | ||
| Q4 24 | $14.9M | $284.8M | ||
| Q3 24 | $13.5M | $157.3M | ||
| Q2 24 | $14.3M | $162.4M | ||
| Q1 24 | — | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $152.0K | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | $151.5K | $-19.5M |
| 自由现金流率自由现金流/营收 | 12.4% | -1042.5% |
| 资本支出强度资本支出/营收 | 0.0% | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $88.8K | $-77.2M |
8季度趋势，按日历期对齐
经营现金流CPHIRGTI
| Q4 25 | $152.0K | $-14.9M | ||
| Q3 25 | $-237.0K | $-13.8M | ||
| Q2 25 | $291.1K | $-16.2M | ||
| Q1 25 | $-57.8K | $-13.7M | ||
| Q4 24 | $298.8K | $-8.5M | ||
| Q3 24 | $-47.0K | $-15.4M | ||
| Q2 24 | $-72.7K | $-13.5M | ||
| Q1 24 | $-585.2K | $-13.1M |
自由现金流CPHIRGTI
| Q4 25 | $151.5K | $-19.5M | ||
| Q3 25 | $-237.6K | $-19.7M | ||
| Q2 25 | $291.0K | $-21.8M | ||
| Q1 25 | $-116.1K | $-16.2M | ||
| Q4 24 | — | $-9.8M | ||
| Q3 24 | $-56.2K | $-17.7M | ||
| Q2 24 | — | $-15.6M | ||
| Q1 24 | — | $-18.6M |
自由现金流率CPHIRGTI
| Q4 25 | 12.4% | -1042.5% | ||
| Q3 25 | -31.4% | -1012.4% | ||
| Q2 25 | 28.4% | -1212.4% | ||
| Q1 25 | -10.2% | -1100.4% | ||
| Q4 24 | — | -432.1% | ||
| Q3 24 | -5.1% | -744.5% | ||
| Q2 24 | — | -504.3% | ||
| Q1 24 | — | -610.5% |
资本支出强度CPHIRGTI
| Q4 25 | 0.0% | 244.8% | ||
| Q3 25 | 0.1% | 302.5% | ||
| Q2 25 | 0.0% | 314.7% | ||
| Q1 25 | 5.1% | 173.0% | ||
| Q4 24 | — | 56.4% | ||
| Q3 24 | 0.8% | 95.8% | ||
| Q2 24 | — | 66.3% | ||
| Q1 24 | — | 180.0% |
现金转化率CPHIRGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPHI
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
